Similar Items: Investigations of Renin-Angiotensin Aldosterone System (RAAS) genes in hypertrophy in hypertrophic cardiomyopathy (HCM) founder families
- The role of renin-angiotensin-aldosterone system (RAAS) genes in the development of hypertrophy in hypertrophic cardiomyopathy (HCM)
- Renin-angiotensin-aldosterone system genes and the complex hypertrophic phenotype of hypertrophic cardiomyopathy
- Sarcomeric modifiers of hypertrophy in hypertrophic cardiomyopathy (HCM)
- Rat angiotensin-converting enzyme : tissue specific expression during pharmacological inhibition
- Luteolin normalizes Blood Pressure via its antioxidant activity and down-regulation of Renal Angiotensin II receptor and Mineralocorticoid receptor expressions in rats co-exposed to Diclofenac and Sodium Fluoride
- The impact of activation of the renin-angiotensin system in the development of insulin resistance in experimental models of obesity
Author: Corfield, Valerie A.
- Molecular and functional characterisation of Long QT Syndrome causing genes
- A candidate and novel gene search to identify the PFHBII-causative gene
- Bioinformatics-based strategies to identify PFHBII-causing and HCM main locus and/or HCM modifying mutations
- An investigation of myosin binding protein C mutations in South Africa and a search for ligands binding to myosin binding protein C
- Investigations of Renin-Angiotensin Aldosterone System (RAAS) genes in hypertrophy in hypertrophic cardiomyopathy (HCM) founder families
- A candidate and novel gene search to identify the PFHBII-causative gene